| |
CVD (n = 118)
|
No CVD (n = 72)
|
p value
|
|---|
|
Gender, male, n (%)
|
74 (62.7%)
|
29 (40.3%)
|
0.003
|
|
Age (years)
|
67 ± 13
|
60 ± 12
|
<0.001
|
|
Dialysis vintage (years)
|
4.3 ± 3.8
|
5.5 ± 6.7
|
0.111
|
|
Current smoking (%)
|
20 (16.9%)
|
5 (6.9%)
|
0.050
|
|
Diabetes, n (%)
|
73 (61.9%)
|
17 (23.6%)
|
<0.001
|
|
ERI (unit/week/kg/Hb)
|
8.5 ± 6.7
|
8.0 ± 4.1
|
0.600
|
|
Hemoglobin (g/dl)
|
10.7 ± 1.2
|
10.7 ± 1.1
|
0.980
|
|
Albumin (g/dl)
|
3.9 ± 0.4
|
4.1 ± 0.4
|
0.005
|
|
Ferritin (mg/dl)
|
418 ± 401
|
458 ± 736
|
0.635
|
|
Iron (mg/dl)
|
65 ± 24
|
68 ± 33
|
0.571
|
|
TIBC (mg/dl)
|
236 ± 47
|
242 ± 54
|
0.441
|
|
Serum i-PTH (pg/mL)
|
277 ± 363
|
422 ± 354
|
0.012
|
|
Kt/V
|
1.44 ± 0.26
|
1.60 ± 0.31
|
0.001
|
|
Cause of ESRD, n (%)
| | |
<0.001
|
|
Hypertension
|
16 (13.5%)
|
18 (25.0%)
| |
|
Diabetes
|
67 (56.8%)
|
17 (23.6%)
| |
|
GN
|
14 (11.9%)
|
22 (30.6%)
| |
|
CHF
|
8 (6.8%)
|
0 (0%)
| |
|
Others
|
13 (11.0%)
|
15 (20.8%)
| |
-
CHF congestive heart failure, ERI erythropoietin resistance index, ESRD end-stage renal disease, GN glomerulonephritis, iPTH parathyroid hormone, Kt/V dialysis adequacy, TIBC total iron-binding capacity. p values of <0.05 are shown in bold
